Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Cencora Dividend Announcement
• Cencora announced a quarterly dividend of $0.55 per ordinary share which will be made payable on 2024-11-29. Ex dividend date: 2024-11-15
• Cencora annual dividend for 2024 was $2.08
• Cencora annual dividend for 2023 was $1.96
• Cencora's trailing twelve-month (TTM) dividend yield is 0.61%
• Cencora's payout ratio for the trailing twelve months (TTM) is 27.50%
• Cencora's dividend growth over the last five years (2018-2023) was 4.99% year
• Cencora's dividend growth over the last ten years (2013-2023) was -13.77% year
Cencora Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-15 | $0.55 | quarterly | 2024-11-29 |
2024-08-09 | $0.51 | quarterly | 2024-08-26 |
2024-05-09 | $0.51 | quarterly | 2024-05-24 |
2024-02-08 | $0.51 | quarterly | 2024-02-26 |
2023-11-10 | $0.51 | quarterly | 2023-11-27 |
2023-08-10 | $0.48 | quarterly | 2023-08-28 |
2023-05-11 | $0.48 | quarterly | 2023-05-30 |
2023-02-09 | $0.48 | quarterly | 2023-02-27 |
2022-11-10 | $0.48 | quarterly | 2022-11-28 |
2022-08-12 | $0.46 | quarterly | 2022-08-29 |
2022-05-13 | $0.46 | quarterly | 2022-05-31 |
2022-02-11 | $0.46 | quarterly | 2022-02-28 |
2021-11-12 | $0.46 | quarterly | 2021-10-15 |
2021-08-13 | $0.44 | quarterly | 2021-07-15 |
2021-05-14 | $0.44 | quarterly | 2021-04-15 |
2021-02-11 | $0.44 | quarterly | 2021-01-15 |
2020-11-13 | $0.44 | quarterly | 2020-10-15 |
2020-08-14 | $0.42 | quarterly | 2020-07-15 |
2020-05-15 | $0.42 | quarterly | 2020-04-15 |
2020-02-13 | $0.42 | quarterly | 2020-01-15 |
2019-11-15 | $0.40 | quarterly | 2019-12-02 |
2019-08-16 | $0.40 | quarterly | 2019-10-15 |
2019-05-17 | $0.40 | quarterly | 2019-07-15 |
2019-02-15 | $0.40 | quarterly | 2019-04-15 |
2018-11-16 | $0.40 | quarterly | 2019-01-15 |
2018-08-17 | $0.38 | quarterly | 2018-10-15 |
2018-05-18 | $0.38 | quarterly | 2018-07-16 |
2018-02-16 | $0.38 | quarterly | 2018-04-16 |
2017-11-17 | $0.38 | quarterly | 2018-01-16 |
2017-08-17 | $0.36 | quarterly | 2017-10-16 |
2017-05-18 | $0.36 | quarterly | 2017-07-17 |
2017-02-16 | $0.36 | quarterly | 2017-04-17 |
2016-11-17 | $0.36 | quarterly | 2017-01-17 |
2016-08-18 | $0.34 | quarterly | 2016-10-17 |
2016-05-19 | $0.34 | quarterly | 2016-07-15 |
2016-02-18 | $0.34 | quarterly | 2016-04-15 |
2015-11-12 | $0.42 | quarterly | 2015-10-15 |
2015-08-13 | $0.29 | quarterly | 2015-09-01 |
2015-05-14 | $0.29 | quarterly | 2015-07-15 |
2015-02-12 | $0.29 | quarterly | 2015-01-15 |
2014-11-13 | $0.29 | quarterly | 2014-12-01 |
2014-08-14 | $0.23 | quarterly | 2014-10-15 |
2014-05-15 | $2.35 | quarterly | 2014-07-15 |
2014-02-13 | $2.35 | quarterly | 2014-04-15 |
2013-11-14 | $2.35 | quarterly | 2014-01-15 |
2013-08-15 | $2.10 | quarterly | 2013-10-15 |
2013-05-16 | $2.10 | quarterly | 2013-07-15 |
2013-02-13 | $2.10 | quarterly | 2013-04-15 |
Cencora Dividend per year
Cencora Dividend growth
Cencora Dividend Yield
Cencora current trailing twelve-month (TTM) dividend yield is 0.61%. Interested in purchasing Cencora stock? Use our calculator to estimate your expected dividend yield:
Cencora Financial Ratios
Cencora Dividend FAQ
Other factors to consider when evaluating Cencora as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Cencora stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Cencora's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Cencora publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Cencora distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Cencora are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Cencora sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Cencora distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Cencora declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Cencora's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Cencora's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.